Company
Lupin LTD
Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
9
6 still marketed
Novel approvals
0
Approvals since 2021
2
Originals and new uses
Phase 3 trials
6
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Ranluspec approved Jun 2, 2026
- Armlupeg approved Nov 28, 2025
- Sesquient approved Nov 5, 2020
- Nikita approved Aug 4, 2017
- Xopenex Hfa new use Mar 12, 2015
- Brovana new use Feb 27, 2014
- Suprax approved Feb 20, 2013
- Suprax approved Jun 1, 2012
- Brovana approved Oct 6, 2006
- Antara (Micronized) new use Oct 21, 2005
Drugs in development (1)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
- Mexiletine granules for prolonged-releasePhase 32 trials
Lupin Ltd. · Myotonic Dystrophy
Recruiting Phase 3 trials
Largest first.
- The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2Pivotal-lookingRecruiting
Lupin Ltd.Industry
NCT06523400 · 176 participants (planned) · Start Feb 13, 2025 · Primary completion Jun 2027
Drug: Mexiletine granules for prolonged-release oral suspension; Placebo · For: Myotonic Dystrophy
Sites: Leuven, Belgium; Aarhus, Denmark; München, Germany · 7 sites in all
- An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IRPivotal-lookingRecruiting
Lupin Ltd.Industry
NCT07097701 · 24 participants (planned) · Start Sep 3, 2025 · Primary completion Jan 22, 2027
Drug: Granular powder in unit dose foil-lined sachet Mexiletine (PR); Oral Capsule Mexiletine (IR) · For: Myotonia
Sites: Leuven, Belgium
Marketed drugs (6)
Newest FDA action first.
- Suprax Cefixime · 2013
- Ranluspec Ranibizumab-Hkdz · 2026
- Armlupeg Pegfilgrastim-Unne · 2025
- Antara (Micronized) Fenofibrate · 2004
- Suprax Cefixime · 2012
- Xopenex Hfa Levalbuterol Tartrate · 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.